GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (XCNQ:BLAB) » Definitions » EBITDA Margin %

Britannia Life Sciences (XCNQ:BLAB) EBITDA Margin % : 40.97% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Britannia Life Sciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Britannia Life Sciences's EBITDA for the three months ended in Dec. 2023 was C$0.74 Mil. Britannia Life Sciences's Revenue for the three months ended in Dec. 2023 was C$1.81 Mil. Therefore, Britannia Life Sciences's EBITDA margin for the quarter that ended in Dec. 2023 was 40.97%.


Britannia Life Sciences EBITDA Margin % Historical Data

The historical data trend for Britannia Life Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences EBITDA Margin % Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23
EBITDA Margin %
55.72 -147.55 108.35

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.53 43.90 29.19 66.88 40.97

Competitive Comparison of Britannia Life Sciences's EBITDA Margin %

For the Biotechnology subindustry, Britannia Life Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Britannia Life Sciences's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's EBITDA Margin % falls into.



Britannia Life Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Britannia Life Sciences's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=6.939/6.404
=108.35 %

Britannia Life Sciences's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0.742/1.811
=40.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences  (XCNQ:BLAB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Britannia Life Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Britannia Life Sciences (XCNQ:BLAB) Business Description

Traded in Other Exchanges
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc is a diversified product development, quality assurance, and safety & regulatory compliance company supporting clients in the CPG, cosmetics, household goods, and nutraceutical industries in the United Kingdom.

Britannia Life Sciences (XCNQ:BLAB) Headlines

No Headlines